[go: up one dir, main page]

EA200600138A1 - Способ получения кристаллического полиморфа ингибитора агрегации тромбоцитов - Google Patents

Способ получения кристаллического полиморфа ингибитора агрегации тромбоцитов

Info

Publication number
EA200600138A1
EA200600138A1 EA200600138A EA200600138A EA200600138A1 EA 200600138 A1 EA200600138 A1 EA 200600138A1 EA 200600138 A EA200600138 A EA 200600138A EA 200600138 A EA200600138 A EA 200600138A EA 200600138 A1 EA200600138 A1 EA 200600138A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inhibitor
crystalline polymorph
obtaining crystalline
aggregation
aggregation inhibitor
Prior art date
Application number
EA200600138A
Other languages
English (en)
Other versions
EA010684B1 (ru
Inventor
Петер Котаи Надь
Дьюла Шимиг
Йожеф Баркоци
Тамаш Грегор
Бела Фаркаш
Дьёрдь Верецкеине Донат
Кальман Надь
Дьюлане Кёртвейэшши
Жужанна Сент-Кирайи
Original Assignee
Эгиш Дьёдьсердьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU0302028A external-priority patent/HU0302028D0/hu
Priority claimed from HU0401272A external-priority patent/HU226773B1/hu
Application filed by Эгиш Дьёдьсердьяр Рт. filed Critical Эгиш Дьёдьсердьяр Рт.
Publication of EA200600138A1 publication Critical patent/EA200600138A1/ru
Publication of EA010684B1 publication Critical patent/EA010684B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Настоящее изобретение относится к новому способу получения полиморфной формы 1 метил (S)-(+)-(2-хлорфенил)-2-(6,7-дигидро-4Н-тиено[3,2-с]пиридин-5-ил-ацетата гидросульфата формулы (I).
EA200600138A 2003-07-02 2004-06-30 Способ получения кристаллического полиморфа ингибитора агрегации тромбоцитов EA010684B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0302028A HU0302028D0 (en) 2003-07-02 2003-07-02 Process for the production of crystalline polymorphous form of an anticoagulant agent
HU0401272A HU226773B1 (en) 2004-06-23 2004-06-23 Process for the production of clopidogrel hydrogensulfate polymorph 1
PCT/HU2004/000070 WO2005003139A1 (en) 2003-07-02 2004-06-30 Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug

Publications (2)

Publication Number Publication Date
EA200600138A1 true EA200600138A1 (ru) 2006-08-25
EA010684B1 EA010684B1 (ru) 2008-10-30

Family

ID=89985327

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600138A EA010684B1 (ru) 2003-07-02 2004-06-30 Способ получения кристаллического полиморфа ингибитора агрегации тромбоцитов

Country Status (14)

Country Link
US (1) US20070142637A1 (ru)
EP (1) EP1644381B1 (ru)
JP (1) JP4681545B2 (ru)
KR (1) KR101155679B1 (ru)
CN (1) CN1812993B (ru)
AT (1) ATE461201T1 (ru)
BG (1) BG109429A (ru)
CA (1) CA2530449C (ru)
CZ (1) CZ200641A3 (ru)
DE (1) DE602004026059D1 (ru)
EA (1) EA010684B1 (ru)
PL (2) PL1644381T3 (ru)
SK (1) SK50102006A3 (ru)
WO (1) WO2005003139A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1740593T1 (sl) * 2004-04-19 2016-08-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo polimorfne oblike I klopidogrel hidrogen sulfata
WO2007032023A2 (en) * 2005-07-12 2007-03-22 Rpg Life Sciences Limited A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
KR20080055860A (ko) * 2006-08-03 2008-06-19 테바 파마슈티컬 인더스트리즈 리미티드 클로피도그렐 바이설페이트의 제조 방법
WO2011010318A1 (en) * 2009-07-23 2011-01-27 Praveen Laboratories Private Limited Process for the preparation of clopidogrel polymorphous form 1 using seed chrystals
CN102070648A (zh) * 2010-12-07 2011-05-25 天津红日药业股份有限公司 I型硫酸氢氯吡格雷的制备方法
CN102702224A (zh) * 2012-06-25 2012-10-03 山东齐都药业有限公司 I型硫酸氢氯吡格雷的制备方法
CN107337683B (zh) * 2017-08-16 2019-08-16 中荣凯特（北京）生物科技有限公司 一种噻吩并吡啶类衍生物硫酸氢盐的晶型ⅱ及其制备方法和应用
CN113121559B (zh) * 2019-12-31 2023-08-29 惠州信立泰药业有限公司 一种高堆密度的ii型硫酸氢氯吡格雷球形结晶及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
CA2436323C (en) * 2001-01-24 2012-02-21 Cadila Healthcare Ltd. Process for preparing clopidogrel
GB0125708D0 (en) * 2001-10-26 2001-12-19 Generics Uk Ltd Novel compounds and processes
WO2003051362A2 (en) * 2001-12-18 2003-06-26 Teva Pharmaceutical Industries Ltd. Polymorphs of clopidogrel hydrogensulfate

Also Published As

Publication number Publication date
SK50102006A3 (sk) 2006-05-04
CZ200641A3 (cs) 2006-05-17
EP1644381A1 (en) 2006-04-12
DE602004026059D1 (de) 2010-04-29
BG109429A (en) 2006-10-31
JP2007516167A (ja) 2007-06-21
CN1812993B (zh) 2011-06-29
ATE461201T1 (de) 2010-04-15
EA010684B1 (ru) 2008-10-30
KR20060026119A (ko) 2006-03-22
JP4681545B2 (ja) 2011-05-11
EP1644381B1 (en) 2010-03-17
PL378710A1 (pl) 2006-05-15
WO2005003139A1 (en) 2005-01-13
US20070142637A1 (en) 2007-06-21
CN1812993A (zh) 2006-08-02
CA2530449C (en) 2010-03-23
KR101155679B1 (ko) 2012-06-13
PL1644381T3 (pl) 2010-08-31
CA2530449A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
EA200800886A1 (ru) Способ получения 1-н-имидазо[4,5-с]пиридинов и их аналогов
EA200400491A1 (ru) Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции
CA2665931C (en) Hydrobenzamide derivatives as inhibitors of hsp90
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
EA200401025A1 (ru) Полиморфы клопидогреля и их применение в качестве антитромботических соединений
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
TW200420541A (en) Crystalline forms
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
GEP20115166B (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
EA200600138A1 (ru) Способ получения кристаллического полиморфа ингибитора агрегации тромбоцитов
WO2004111008A3 (en) Use of a compound of formula i for making a pharmaceutical composition
ATE441627T1 (de) Verfahren zur herstellung von valsartan
WO2005005394A3 (en) Thiophenylaminoimidazolines as prostaglandin i2 antagonists
WO2006066044A3 (en) Processes for producing 4-aminoquinazolines
EA200501527A1 (ru) Способ получения полиморфа малеата розиглитазона
EA200870038A1 (ru) Способ получения аминов
BRPI0417300A (pt) métodos para a preparação de compostos de tiazolpirimidina
WO2005054175A3 (en) New process for the preparation of nitrooxyderivatives of paracetamol
CY1112457T1 (el) Χρωμανο- και θειοxρωμανο-3-υλο-1,3-διυδρο-ιμιδαζολια ως αναστολεις της ντοπαμινο-β-υδροξυλασης, και μεθοδοι παρασκευης αυτων
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
EA200800200A1 (ru) Способ получения кристаллического периндоприла
NO20052197L (no) Fremgangsmate for fremstilling av pyrazol
BG109428A (en) METHOD FOR OBTAINING AMORPHIC FORM OF MEDICINES INHIBITION OF THERAPEUTIC AGGREGATION
WO2004078107A3 (fr) Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU